Takeda Pharmaceutical Cash on Hand 2012-2025 | TAK

Takeda Pharmaceutical cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.

Takeda Pharmaceutical cash on hand for the quarter ending September 30, 2025 was $2.892B, a 25.57% increase year-over-year.
Takeda Pharmaceutical cash on hand for 2025 was $2.677B, a 17.96% decline from 2024.
Takeda Pharmaceutical cash on hand for 2024 was $3.263B, a 20.37% decline from 2023.
Takeda Pharmaceutical cash on hand for 2023 was $4.097B, a 47.38% decline from 2022.

Takeda Pharmaceutical Annual Cash on Hand (Millions of US $)
2025	$2,677
2024	$3,263
2023	$4,097
2022	$7,788
2021	$9,427
2020	$6,012
2019	$6,528
2018	$3,377
2017	$3,498
2016	$4,648
2015	$6,492
2014	$8,510
2013	$6,627
2012	$5,786
2011	$10,533

Takeda Pharmaceutical Quarterly Cash on Hand (Millions of US $)
2025-06-30	$2,892
2024-06-30	$5,489
2024-03-31	$3,263
2023-12-31	$2,158
2023-09-30	$2,303
2023-06-30	$2,691
2023-03-31	$4,097
2022-12-31	$5,159
2022-09-30	$5,976
2022-06-30	$5,117
2022-03-31	$7,788
2021-12-31	$6,617
2021-09-30	$5,766
2021-06-30	$6,232
2021-03-31	$9,427
2020-12-31	$6,281
2020-09-30	$6,074
2020-06-30	$5,589
2020-03-31	$6,012
2019-12-31	$5,413
2019-09-30	$5,184
2019-06-30	$5,597
2018-12-31	$16,591
2018-06-30	$2,306
2017-06-30	$4,413
2016-06-30	$6,815
2015-06-30	$5,231
2015-03-31	$6,492
2014-12-31	$7,537
2014-09-30	$8,077
2014-06-30	$7,475
2014-03-31	$8,510
2013-12-31	$7,326
2013-09-30	$7,263
2013-06-30	$3,887
2013-03-31	$6,627
2012-12-31	$5,192
2012-09-30	$5,233
2012-06-30	$4,767
2012-03-31	$5,786
2011-12-31	$4,959
2011-09-30	$5,237
2011-03-31	$10,533

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$51.421B	$30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$85.303B	32.40
Zoetis (ZTS)	United States	$54.932B	19.66
Daiichi Sankyo, - (DSNKY)	Japan	$39.630B	19.74
BeOne Medicines - (ONC)	Switzerland	$37.087B	196.62
Sandoz Group AG (SDZNY)	Switzerland	$33.939B	0.00
United Therapeutics (UTHR)	United States	$20.018B	17.62
Merck (MKKGY)	Germany	$19.496B	12.02
Shionogi (SGIOY)	Japan	$15.261B	14.02
Neurocrine Biosciences (NBIX)	United States	$13.200B	31.67
Summit Therapeutics (SMMT)	United States	$13.140B	0.00
IPSEN (IPSEY)	France	$13.109B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.363B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.394B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.236B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$5.981B	33.47
Crinetics Pharmaceuticals (CRNX)	United States	$5.313B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.216B	20.01
Indivior (INDV)	United States	$4.068B	16.60
Corcept Therapeutics (CORT)	United States	$3.653B	39.47
NewAmsterdam Pharma (NAMS)	Netherlands	$3.589B	0.00
Hypermarcas (HYPMY)	Brazil	$3.047B	20.91
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.984B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.790B	8.90
Ocular Therapeutix (OCUL)	United States	$2.401B	0.00
Dyne Therapeutics (DYN)	United States	$2.386B	0.00
Soleno Therapeutics (SLNO)	United States	$2.282B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.958B	23.20
Harrow (HROW)	United States	$1.774B	108.86
Guardian Pharmacy Services (GRDN)	United States	$1.712B	32.96
Ardelyx (ARDX)	United States	$1.640B	0.00
Oruka Therapeutics (ORKA)	United States	$1.617B	0.00
Enliven Therapeutics (ELVN)	United States	$1.585B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.570B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.441B	7.14
BioCryst Pharmaceuticals (BCRX)	United States	$1.404B	83.25
Evotec AG (EVO)	Germany	$1.282B	0.00
Relay Therapeutics (RLAY)	United States	$1.274B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.248B	0.00
Savara (SVRA)	United States	$1.184B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.051B	0.00
Theravance Biopharma (TBPH)	United States	$1.014B	42.57
Cronos Group (CRON)	Canada	$0.967B	0.00
Xencor (XNCR)	United States	$0.913B	0.00
Nektar Therapeutics (NKTR)	United States	$0.766B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.738B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.732B	17.31
Esperion Therapeutics (ESPR)	United States	$0.727B	0.00
ProKidney (PROK)	United States	$0.689B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.680B	6.07
Bioventus (BVS)	United States	$0.656B	13.44
Lexeo Therapeutics (LXEO)	United States	$0.539B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.506B	0.00
Lyell Immunopharma (LYEL)	United States	$0.505B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.503B	0.00
Organogenesis (ORGO)	United States	$0.481B	0.00
Siga Technologies (SIGA)	United States	$0.471B	6.45
Altimmune (ALT)	United States	$0.442B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.431B	0.00
Nature's Sunshine Products (NATR)	United States	$0.421B	25.07
Aquestive Therapeutics (AQST)	United States	$0.404B	0.00
USANA Health Sciences (USNA)	United States	$0.401B	11.19
Akebia Therapeutics (AKBA)	United States	$0.361B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.310B	0.00
Profound Medical (PROF)	Canada	$0.298B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.284B	0.00
Avalo Therapeutics (AVTX)	United States	$0.279B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.279B	0.00
Relmada Therapeutics (RLMD)	United States	$0.274B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Fractyl Health (GUTS)	United States	$0.262B	0.00
Larimar Therapeutics (LRMR)	United States	$0.259B	0.00
Protara Therapeutics (TARA)	United States	$0.259B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.238B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.223B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.209B	0.00
Galectin Therapeutics (GALT)	United States	$0.196B	0.00
Minerva Neurosciences (NERV)	United States	$0.193B	0.00
Century Therapeutics (IPSC)	United States	$0.190B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
MediWound (MDWD)	Israel	$0.180B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
AleAnna (ANNA)	United States	$0.171B	0.00
VAXART, INC (VXRT)	United States	$0.169B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.146B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Context Therapeutics (CNTX)	United States	$0.132B	0.00
Incannex Healthcare (IXHL)	Australia	$0.131B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Avita Medical (RCEL)	United States	$0.119B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.116B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.114B	0.00
Pyxis Oncology (PYXS)	United States	$0.110B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.105B	0.00
Champions Oncology (CSBR)	United States	$0.100B	42.41
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Korro Bio (KRRO)	United States	$0.083B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Gain Therapeutics (GANX)	United States	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.13
PolyPid (PYPD)	Israel	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.067B	0.00
Arch Biopartners (ACHFF)	Canada	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.060B	0.00
ElectroCore (ECOR)	United States	$0.057B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Lite Strategy (LITS)	United States	$0.053B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.048B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.037B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.030B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.020B	0.00
Inotiv (NOTV)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Vyome Holdings (HIND)	United States	$0.016B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00